...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM
3
Nov 22, 2023 09:54AM
2
Nov 22, 2023 12:12PM
3
Nov 22, 2023 02:03PM
2
Nov 22, 2023 03:24PM
4
Nov 22, 2023 04:23PM
5
Nov 22, 2023 05:06PM
4
Nov 22, 2023 06:20PM
5
Nov 22, 2023 07:31PM
1
Nov 23, 2023 08:16PM
6
Nov 24, 2023 08:38AM
6
Nov 24, 2023 09:41PM

"the initial focus of Cencora’s work will be in evaluating regulatory and market access to provide insights into potential barriers and opportunities for ZEN-3694's introduction"

wonder what Donald will say when Cencora tells him that he is the largest "potential barrier" in moving this science & company forward??

2
Nov 27, 2023 11:34PM
5
Dec 01, 2023 01:59PM
Share
New Message
Please login to post a reply